We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Court Denies Teva Advance Notice on Launch of Generic Copaxone
Court Denies Teva Advance Notice on Launch of Generic Copaxone
October 26, 2010
Sandoz and Momenta Pharmaceuticals would be able to bring their generic version of the multiple sclerosis drug Copaxone to market without first notifying Teva, a federal court has ruled.